Capvizr
News · All summaries
Healthcare & Life Sciences
XCath
Series C$30 million
RoundSeries C
Amount$30 million
DateApril 14, 2026
THE DEAL, AT A GLANCE

XCath

From the announcement
What happenedXCath raised $30M Series C, announced 2026-04-14From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersXCath's $30M Series C supports a neurovascular care company seeking to improve global outcomes, with the investment case likely depending on whether the company can…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

XCath · Financing Record

Explore source-linked visual explanations for XCath. Unsupported claims are withheld while source review continues.

Record 2575 · Recorded date: 2026-04-14

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime